Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
ESMO Open|September 12, 2025
Exploring the impact of NGS on diagnostics and treatment of sarcoma: insights from real-world data across multiple institutions in EuropeA Kyriazoglou, A Zając, C Valverde, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 9, 2016
The interval between primary melanoma excision and sentinel node biopsy is not associated with survival in sentinel node positive patients - An EORTC Melanoma Group studyC M C Oude Ophuis, C Verhoef, P Rutkowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2014
Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trialsA Le Cesne, M Ouali, M G Leahy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2021
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)☆P G Casali, A Le Cesne, A P Velasco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'P Schöffski, A Wozniak, S Stacchiotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 23, 2026
IO102-IO103 immune-modulatory cancer vaccine and pembrolizumab in melanomaJ C Hassel, A Arance, M S Carlino, et al.
The British Journal of Dermatology|January 25, 2017
Electrochemotherapy in the treatment of metastatic malignant melanoma: a prospective cohort study by InspECTC Kunte, V Letulé, J Gehl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 8, 2017
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'P Schöffski, A Wozniak, B Kasper, et al.
ESMO Open|November 28, 2023
Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registryN Hindi, A Razak, E Rosenbaum, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2024
An update on access to novel treatment for metastatic melanoma in Europe - A 2024 survey of the European melanoma registry and the European association of dermato-oncologyL Kandolf, P A Ascierto, L Bastholt, et al.
Pageof 12